Document is current
Any future updates will be listed below
-
Authors
Fagherazzi, Guy https://orcid.org/0000-0001-5033-5966
Serusclat, Pierre
Roux, Barbara https://orcid.org/0000-0002-0303-1246
Bretin, Oriane
Casarotto, Emilie https://orcid.org/0000-0003-1891-417X
Rabiéga, Pascaline
Rabat, Yolaine https://orcid.org/0000-0002-1244-0535
Berteau, Cécile
Pouyet, Antoine
Joubert, Michael https://orcid.org/0000-0002-8731-7355
-
Funding
Funding for this research was provided by:
Roche Diabetes Care
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 1 August 2025
First Online: 3 September 2025
Declarations
:
: Guy Fagherazzi has provided advisory/speaking services and/or has received research grants and/or speaker honoraria from MSD, MSDAvenir, Eli Lilly, Roche Diabetes Care, Sanofi, AstraZeneca, Danone Research, Diabeloop, Bristol Myers Squibb, L'Oréal R&D, Abbvie Pharmaceutical, Pfizer, Vitalaire and Akuity Care. Michael Joubert declares consultant and/or speaker fees and/or research support from Abbott, Air Liquide Santé International, Amgen, Asdia, AstraZeneca, Bayer, BMS, Boehringer-Ingelheim, Dexcom, Dinno Santé, Glooko, Insulet, Lifescan, Lilly, LVL médical, Medtronic, MSD, Nestle HomeCare, Novonordisk, Organon, Orkyn, Roche Diabetes, Sanofi, Tandem, Vitalaire, Voluntis, Ypsomed. Michael Joubert is an Editorial Board Member of Diabetes Therapy. Michael Joubert was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Pierre Serusclat has provided advisory/speaking services and/or research support from Roche Diabetes Care as an expert on the scientific committee of the present study. Cécile Berteau and Antoine Pouyet are employees of Roche Diagnostics France and Timkl France, respectively. Oriane Bretin, Emilie Casarotto, Yolaine Rabat, Pascaline Rabiéga and Barbara Roux are employees of IQVIA RWS France.
: The study was approved by the French Data Protection Supervisory Authority “Commission Nationale Informatique et Libertés” (CNIL) (authorization no. 919119). As this study was a retrospective analysis of data from the SNDS, no informed consent was required and therefore not obtained. Retrospective analysis of pseudonymized data and therefore consent for publication is not required.
